USPTO serial 79364021
SEPSIA THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 19, 2024
- Examiner
- DAVIS, MARC STEPHEN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEPSIA THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth Lee D'Amore
Elizabeth Lee D'Amore Lucas & Mercanti, LLP100 S. Jefferson Road, Suite 202Whippany, NJ 07981United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products namely, pharmaceutical preparations for human and veterinary use for the treatment of infectious diseases, inflammatory conditions, sepsis, advanced cell therapies and immunotherapy; biological preparations for medical and veterinary use, namely, biological preparations for the treatment of infectious diseases; pharmaceutical, biological and veterinary preparations for the treatment of infectious diseases and related inflammatory processes, for the treatment of sepsis and for advanced cell therapies and immunotherapy; pharmaceutical preparations containing nucleic acids and proteins and active peptides for medical and veterinary use, namely, pharmaceutical preparations containing nucleic acids and proteins and active peptides for the treatment of infectious diseases and related inflammatory processes, for the treatment of sepsis and for advanced cell therapies and immunotherapy | ACTIVE | — |
| 010 | Medical machines for dialysis, hemoperfusion and hemoadsorption; medical devices for blood purification, namely, hemoperfusion machines; medical adsorption devices and polymeric adsorption materials for the removal of materials from the blood or from blood fractions and kits primarily containing said testing devices for the identification of bacteria for medical use; electrical instruments for medical use in blood diagnostic analysis; assay instruments for medical diagnostic use in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; medical diagnostic testing instruments for use in immunoassay procedures; diagnostic apparatus for medical use in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; medical diagnostic testing apparatus for use in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for immunoassay procedures; apparatus and instruments for diagnostic testing for medical purposes in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; apparatus and instruments for veterinary diagnosis in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; medical diagnostic instruments for diagnosis in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; dialysis apparatus, namely, dialysis and hemofiltration machines; dialysis machines for veterinary use, namely, dialysis and hemofiltration machines; dialysis machines for medical use | ACTIVE | — |
| 042 | Scientific and technological services, as well as associated research and design services, namely, scientific research and development in the fields of biochemicals, pharmacy, medicine and veterinary medicine; industrial analysis services related to biology, biochemistry, chemistry, pharmacy, medicine and veterinary medicine, industrial research in the fields of biology, biochemistry, chemistry, pharmacy, medicine and veterinary medicine; scientific research services related to biology, biochemistry, chemistry, pharmacy, medicine and veterinary medicine; scientific research services related to the treatment of infectious diseases and related inflammatory processes, sepsis and advanced cell therapies and immunotherapy; scientific research services related to peptides and proteins for pharmaceutical, medical and veterinary use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SEPSIA THERAPEUTICS, S.L.
- Other trademarks owned by SEPSIA THERAPEUTICS, S.L.
- Other trademarks owned by SEPSIA THERAPEUTICS, S.L.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named SEPSIA THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 4, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 4, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 4, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 4, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 3, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 14, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 14, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 19, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 19, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 19, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 17, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 14, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 31, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 31, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 25, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 25, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 25, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 25, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 25, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 24, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 24, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 24, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 25, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 25, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 24, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 24, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 11, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 11, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 19, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 18, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 2, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |